发明名称 |
VERFAHREN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT KONTROLLIERTER FREISETZUNG EINES 4-(2,1,3-BENZOXADIAZOL-4-YL)-1,4-DIHYDRO- 2,6-DIMETHYL-3,5-PYRIDINDICARBOXYLATESTER- WIRKSTOFFES |
摘要 |
Case 100-6717 A controlled release formulation for oral administration comprising - an active substance chosen from the group of Pindolol and a 4-(2,1, 3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester, - a pharmaceutically acceptable hydrophilic swellable substance and containing optionally a pharmaceutically acceptable inert fatty material in addition. The formulation has an excellent bioavailability and practically no food interaction after administration. 3700/KD/AB |
申请公布号 |
ATA260486(A) |
申请公布日期 |
1996.08.15 |
申请号 |
AT19860002604 |
申请日期 |
1986.09.30 |
申请人 |
SANDOZ-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H. |
发明人 |
|
分类号 |
A61K9/20;A61K9/26;A61K9/48;A61K9/52;A61K31/40;A61K31/44 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|